Clinical Trials Update: July 31, 2007
COPD (Chronic Obstructive Pulmonary Disease) Diabetes Mellitus Types I and II Chronic Myeloid Leukemia
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
COPD (Chronic Obstructive Pulmonary Disease)
This study will compare the effectiveness of two investigational medications in people with COPD. The trial will last 35 days and require three clinic visits and at least one telephone call. Candidates must be at least 45 and have used the Spiriva HandiHaler.
The research site is in Panama City, Fla.
Diabetes Mellitus Types I and II
This study is for adults who are using metformin (Glucophage) to treat type 2 diabetes, but are having difficulty controlling blood sugar levels. If you qualify, the study may last up to 9 months, and you can continue taking current medications. All study related treatments and procedures are provided at no cost, and you may be compensated for time and travel. Health insurance isn't required.
The research site is in Suffolk, Va.
Chronic Myeloid Leukemia
This study will evaluate the effectiveness and safety of an experimental drug, flavopiridol, in treating acute leukemias. Candidates with acute leukemias must be ages 1 to 17 years old to participate.
The research site is in Cincinnati, Ohio.
Copyright 2007 Thomson CenterWatch. All rights reserved.